198130-52-8

Upstream product

• 160088-53-9 N-(5-chloro-4-methoxy-2-nitrophenyl)-acetamide 
• 95-77-2 3,4-dichlorophenol 
• 198130-51-7 2-nitro-4-methoxy-5-(3,4-dichlorophenoxy)acetanilide 

Downstream Products

• 82333-39-9 5-(3,4-dichlorophenoxy)-6-methoxy-4-methyl-8-nitroquinoline 
• 80061-29-6 8-[(4-amino-1-methylbutyl)amino]-5-(3,4-dichlorophenoxy)-6-methoxy-4-methyl-quinoline 
• 82333-48-0 2-{4-[5-(3,4-Dichloro-phenoxy)-6-methoxy-4-methyl-quinolin-8-ylamino]-pentyl}-isoindole-1,3-dione 
• 82333-43-5 8-amino-5-(3,4-dichlorophenoxy)-6-methoxy-4-methylquinoline 
• 886054-44-0 (+/-)-8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate 

Relevant academic research and scientific papers

Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs

8-Aminoquinolines (8-AQs) are important class of anti-infective therapeutics. 5-Phenoxy 8-aminoquinoline analogs have shown improved metabolic stability compared to primaquine. In view or predictive role of monoamine oxidases (MAO) in metabolism of 8-amin

8-AMINOQUINOLINES

It has been found that one of the enantiomers of 8-aminoquinoline antiparasitic compounds is surprisingly more active than the other enantiomer against parasitic infections including opportunistic parasitic infections. These enantiomers as well as pharmac